25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CHJTF (Cspc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cspc together

I guess you are interested in CSPC Pharmaceutical Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Cspc’s Financial Insights
  • 📈 Technical Analysis (TA) – Cspc’s Price Targets

I'm going to help you getting a better view of CSPC Pharmaceutical Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CSPC Pharmaceutical Group Ltd

I send you an email if I find something interesting about CSPC Pharmaceutical Group Ltd.

1. Quick Overview

1.1. Quick analysis of Cspc (30 sec.)










1.2. What can you expect buying and holding a share of Cspc? (30 sec.)

How much money do you get?

How much money do you get?
$0.15
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$0.40
Expected worth in 1 year
$0.37
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$0.12
Return On Investment
11.2%

For what price can you sell your share?

Current Price per Share
$1.05
Expected price per share
$1.05 - $1.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cspc (5 min.)




Live pricePrice per Share (EOD)
$1.05
Intrinsic Value Per Share
$-0.02 - $0.45
Total Value Per Share
$0.38 - $0.85

2.2. Growth of Cspc (5 min.)




Is Cspc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.7b$4.8b-$160.6m-3.4%

How much money is Cspc making?

Current yearPrevious yearGrowGrow %
Making money$603.7m$819.3m-$215.5m-35.7%
Net Profit Margin14.9%17.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cspc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cspc?

Welcome investor! Cspc's management wants to use your money to grow the business. In return you get a share of Cspc.

First you should know what it really means to hold a share of Cspc. And how you can make/lose money.

Speculation

The Price per Share of Cspc is $1.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cspc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cspc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.40. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cspc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.054.9%0.054.9%0.076.6%0.066.1%0.066.0%0.054.5%
Usd Book Value Change Per Share-0.01-0.9%-0.01-0.9%-0.01-0.8%0.010.5%0.032.8%0.033.1%
Usd Dividend Per Share0.043.7%0.043.7%0.033.1%0.033.1%0.032.7%0.021.8%
Usd Total Gains Per Share0.032.8%0.032.8%0.022.3%0.043.6%0.065.5%0.054.9%
Usd Price Per Share0.59-0.59-0.80-0.80-0.88-0.53-
Price to Earnings Ratio11.47-11.47-11.59-12.41-13.89-9.46-
Price-to-Total Gains Ratio20.02-20.02-33.19-23.22-18.59-20.16-
Price to Book Ratio1.47-1.47-1.94-1.94-2.31-1.67-
Price-to-Total Gains Ratio20.02-20.02-33.19-23.22-18.59-20.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.05
Number of shares952
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share-0.010.03
Usd Total Gains Per Share0.030.06
Gains per Quarter (952 shares)28.0654.94
Gains per Year (952 shares)112.24219.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1146-34102109111210
2293-68214218222430
3439-102326326333650
4585-136438435444870
5732-1715505445551090
6878-2056626536661310
71024-2397747617771530
81171-2738868708881750
91317-3079989799991970
101463-3411110108811102190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%18.04.00.081.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.08.063.6%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.02.00.090.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CSPC Pharmaceutical Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.009-0.0090%-0.008-11%0.005-269%0.029-131%0.032-128%
Book Value Per Share--0.4020.4020%0.411-2%0.411-2%0.389+4%0.273+48%
Current Ratio--2.2722.2720%2.627-13%2.524-10%2.583-12%2.364-4%
Debt To Asset Ratio--0.2370.2370%0.243-3%0.239-1%0.232+2%0.270-12%
Debt To Equity Ratio--0.3260.3260%0.339-4%0.331-1%0.317+3%0.385-15%
Dividend Per Share--0.0380.0380%0.032+20%0.033+16%0.029+35%0.019+102%
Enterprise Value--6608446965.0006608446965.0000%9753447400.500-32%9676193056.493-32%10809973126.033-39%10784658109.912-39%
Eps--0.0510.0510%0.069-25%0.064-20%0.063-19%0.048+8%
Ev To Ebitda Ratio--6.8056.8050%8.194-17%8.497-20%9.245-26%10.099-33%
Ev To Sales Ratio--1.6331.6330%2.021-19%2.059-21%2.408-32%2.696-39%
Free Cash Flow Per Share--0.0220.0220%0.027-18%0.040-45%0.046-53%0.033-33%
Free Cash Flow To Equity Per Share---0.040-0.0400%-0.003-92%0.000-9390%0.013-417%0.014-381%
Gross Profit Margin---1.001-1.0010%-0.712-29%-0.804-20%-0.818-18%-0.378-62%
Intrinsic Value_10Y_max--0.452----------
Intrinsic Value_10Y_min---0.024----------
Intrinsic Value_1Y_max--0.046----------
Intrinsic Value_1Y_min--0.024----------
Intrinsic Value_3Y_max--0.138----------
Intrinsic Value_3Y_min--0.050----------
Intrinsic Value_5Y_max--0.230----------
Intrinsic Value_5Y_min--0.051----------
Market Cap11989740134.400+42%6925445370.0006925445370.0000%9498424800.000-27%9487192800.000-27%10522006236.000-34%6341552628.298+9%
Net Profit Margin--0.1490.1490%0.170-12%0.163-8%0.168-11%0.168-11%
Operating Margin--0.1940.1940%0.214-10%0.205-5%0.223-13%0.229-16%
Operating Ratio--0.8150.8150%0.778+5%0.791+3%0.786+4%0.789+3%
Pb Ratio2.609+44%1.4661.4660%1.944-25%1.940-24%2.310-37%1.671-12%
Pe Ratio20.414+44%11.47111.4710%11.593-1%12.410-8%13.887-17%9.458+21%
Price Per Share1.050+44%0.5900.5900%0.800-26%0.800-26%0.884-33%0.532+11%
Price To Free Cash Flow Ratio47.608+44%26.75126.7510%29.789-10%23.594+13%21.728+23%15.379+74%
Price To Total Gains Ratio35.622+44%20.01620.0160%33.194-40%23.224-14%18.588+8%20.156-1%
Quick Ratio--2.0412.0410%2.386-14%2.378-14%2.428-16%2.005+2%
Return On Assets--0.0980.0980%0.127-23%0.118-17%0.126-23%0.131-26%
Return On Equity--0.1340.1340%0.177-24%0.164-18%0.172-22%0.186-28%
Total Gains Per Share--0.0290.0290%0.024+22%0.038-23%0.058-49%0.051-43%
Usd Book Value--4724347455.0004724347455.0000%4885012674.000-3%4869203905.274-3%4618254921.808+2%3234645557.618+46%
Usd Book Value Change Per Share---0.009-0.0090%-0.008-11%0.005-269%0.029-131%0.032-128%
Usd Book Value Per Share--0.4020.4020%0.411-2%0.411-2%0.389+4%0.273+48%
Usd Dividend Per Share--0.0380.0380%0.032+20%0.033+16%0.029+35%0.019+102%
Usd Enterprise Value--6608446965.0006608446965.0000%9753447400.500-32%9676193056.493-32%10809973126.033-39%10784658109.912-39%
Usd Eps--0.0510.0510%0.069-25%0.064-20%0.063-19%0.048+8%
Usd Free Cash Flow--258882426.000258882426.0000%318861846.000-19%474326442.365-45%553867750.279-53%390877386.543-34%
Usd Free Cash Flow Per Share--0.0220.0220%0.027-18%0.040-45%0.046-53%0.033-33%
Usd Free Cash Flow To Equity Per Share---0.040-0.0400%-0.003-92%0.000-9390%0.013-417%0.014-381%
Usd Market Cap11989740134.400+42%6925445370.0006925445370.0000%9498424800.000-27%9487192800.000-27%10522006236.000-34%6341552628.298+9%
Usd Price Per Share1.050+44%0.5900.5900%0.800-26%0.800-26%0.884-33%0.532+11%
Usd Profit--603760882.500603760882.5000%819328837.500-26%757612875.000-20%754906761.000-20%558972596.065+8%
Usd Revenue--4046790933.0004046790933.0000%4826612620.967-16%4630678264.107-13%4497405366.133-10%3323810455.178+22%
Usd Total Gains Per Share--0.0290.0290%0.024+22%0.038-23%0.058-49%0.051-43%
 EOD+4 -4MRQTTM+0 -0YOY+10 -303Y+7 -335Y+9 -3110Y+16 -24

3.3 Fundamental Score

Let's check the fundamental score of CSPC Pharmaceutical Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.414
Price to Book Ratio (EOD)Between0-12.609
Net Profit Margin (MRQ)Greater than00.149
Operating Margin (MRQ)Greater than00.194
Quick Ratio (MRQ)Greater than12.041
Current Ratio (MRQ)Greater than12.272
Debt to Asset Ratio (MRQ)Less than10.237
Debt to Equity Ratio (MRQ)Less than10.326
Return on Equity (MRQ)Greater than0.150.134
Return on Assets (MRQ)Greater than0.050.098
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of CSPC Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.962
Ma 20Greater thanMa 501.047
Ma 50Greater thanMa 1000.858
Ma 100Greater thanMa 2000.714
OpenGreater thanClose1.050
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. It also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, the company provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food products; and healthcare services. It has a strategic collaboration with AstraZeneca PLC to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.

Fundamental data was last updated by Penke on 2025-07-11 11:31:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cspc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 14.9% means that $0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 14.9%. The company is making a huge profit. +2
  • The TTM is 14.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.9%TTM14.9%0.0%
TTM14.9%YOY17.0%-2.1%
TTM14.9%5Y16.8%-1.9%
5Y16.8%10Y16.8%+0.0%
4.3.1.2. Return on Assets

Shows how efficient Cspc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • 9.8% Return on Assets means that Cspc generated $0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 9.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.8%TTM9.8%0.0%
TTM9.8%YOY12.7%-2.9%
TTM9.8%5Y12.6%-2.9%
5Y12.6%10Y13.1%-0.5%
4.3.1.3. Return on Equity

Shows how efficient Cspc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • 13.4% Return on Equity means Cspc generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 13.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.4%TTM13.4%0.0%
TTM13.4%YOY17.7%-4.3%
TTM13.4%5Y17.2%-3.8%
5Y17.2%10Y18.6%-1.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CSPC Pharmaceutical Group Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cspc is operating .

  • Measures how much profit Cspc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 19.4% means the company generated $0.19  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 19.4%. The company is operating efficient. +1
  • The TTM is 19.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ19.4%TTM19.4%0.0%
TTM19.4%YOY21.4%-2.1%
TTM19.4%5Y22.3%-2.9%
5Y22.3%10Y22.9%-0.6%
4.3.2.2. Operating Ratio

Measures how efficient Cspc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.82 means that the operating costs are $0.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.815. The company is less efficient in keeping operating costs low.
  • The TTM is 0.815. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.815TTM0.8150.000
TTM0.815YOY0.778+0.037
TTM0.8155Y0.786+0.029
5Y0.78610Y0.789-0.002
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CSPC Pharmaceutical Group Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cspc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.27 means the company has $2.27 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 2.272. The company is able to pay all its short-term debts. +1
  • The TTM is 2.272. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.272TTM2.2720.000
TTM2.272YOY2.627-0.355
TTM2.2725Y2.583-0.311
5Y2.58310Y2.364+0.219
4.4.3.2. Quick Ratio

Measures if Cspc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 2.04 means the company can pay off $2.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 2.041. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.041. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.041TTM2.0410.000
TTM2.041YOY2.386-0.345
TTM2.0415Y2.428-0.387
5Y2.42810Y2.005+0.423
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CSPC Pharmaceutical Group Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cspc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cspc to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.24 means that Cspc assets are financed with 23.7% credit (debt) and the remaining percentage (100% - 23.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.237. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.237. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.237TTM0.2370.000
TTM0.237YOY0.243-0.006
TTM0.2375Y0.232+0.005
5Y0.23210Y0.270-0.038
4.5.4.2. Debt to Equity Ratio

Measures if Cspc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 32.6% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The MRQ is 0.326. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.326. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.326TTM0.3260.000
TTM0.326YOY0.339-0.013
TTM0.3265Y0.317+0.009
5Y0.31710Y0.385-0.068
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cspc generates.

  • Above 15 is considered overpriced but always compare Cspc to the Drug Manufacturers - General industry mean.
  • A PE ratio of 11.47 means the investor is paying $11.47 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The EOD is 20.414. Based on the earnings, the company is fair priced.
  • The MRQ is 11.471. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.471. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.414MRQ11.471+8.943
MRQ11.471TTM11.4710.000
TTM11.471YOY11.593-0.122
TTM11.4715Y13.887-2.416
5Y13.88710Y9.458+4.429
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The EOD is 47.608. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 26.751. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 26.751. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD47.608MRQ26.751+20.857
MRQ26.751TTM26.7510.000
TTM26.751YOY29.789-3.037
TTM26.7515Y21.728+5.024
5Y21.72810Y15.379+6.349
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cspc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.47 means the investor is paying $1.47 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CSPC Pharmaceutical Group Ltd:

  • The EOD is 2.609. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.466. Based on the equity, the company is underpriced. +1
  • The TTM is 1.466. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.609MRQ1.466+1.143
MRQ1.466TTM1.4660.000
TTM1.466YOY1.944-0.478
TTM1.4665Y2.310-0.845
5Y2.31010Y1.671+0.640
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets44,388,991
Total Liabilities10,522,701
Total Stockholder Equity32,264,695
 As reported
Total Liabilities 10,522,701
Total Stockholder Equity+ 32,264,695
Total Assets = 44,388,991

Assets

Total Assets44,388,991
Total Current Assets21,888,144
Long-term Assets22,500,847
Total Current Assets
Cash And Cash Equivalents 6,777,199
Short-term Investments 1,473,112
Net Receivables 9,938,393
Inventory 3,130,014
Other Current Assets 569,426
Total Current Assets  (as reported)21,888,144
Total Current Assets  (calculated)21,888,144
+/-0
Long-term Assets
Property Plant Equipment 13,079,000
Goodwill 234,904
Intangible Assets 2,609,506
Long-term Assets Other 1,529,239
Long-term Assets  (as reported)22,500,847
Long-term Assets  (calculated)17,452,649
+/- 5,048,198

Liabilities & Shareholders' Equity

Total Current Liabilities9,634,027
Long-term Liabilities888,674
Total Stockholder Equity32,264,695
Total Current Liabilities
Short-term Debt 451,195
Short Long Term Debt 392,204
Accounts payable 2,613,000
Other Current Liabilities 6,235,601
Total Current Liabilities  (as reported)9,634,027
Total Current Liabilities  (calculated)9,692,000
+/- 57,973
Long-term Liabilities
Capital Lease Obligations 115,126
Long-term Liabilities  (as reported)888,674
Long-term Liabilities  (calculated)115,126
+/- 773,548
Total Stockholder Equity
Common Stock11,032,752
Retained Earnings 23,344,080
Other Stockholders Equity -2,112,137
Total Stockholder Equity (as reported)32,264,695
Total Stockholder Equity (calculated)32,264,695
+/-0
Other
Capital Stock11,032,752
Cash and Short Term Investments 8,250,311
Common Stock Shares Outstanding 11,738,043
Liabilities and Stockholders Equity 44,388,991
Net Debt -6,269,869
Net Invested Capital 32,656,899
Net Working Capital 12,254,117
Property Plant and Equipment Gross 19,447,132
Short Long Term Debt Total 507,330



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
3,575,599
5,015,089
5,588,872
5,278,431
2,058,732
6,958,984
7,886,655
8,282,937
8,869,280
10,887,603
9,420,928
9,938,615
11,275,569
13,216,321
18,001,216
22,694,427
29,439,554
35,652,446
42,498,176
46,896,586
46,282,170
44,388,991
44,388,99146,282,17046,896,58642,498,17635,652,44629,439,55422,694,42718,001,21613,216,32111,275,5699,938,6159,420,92810,887,6038,869,2808,282,9377,886,6556,958,9842,058,7325,278,4315,588,8725,015,0893,575,599
   > Total Current Assets 
1,429,267
1,584,138
1,982,678
1,772,235
821,228
3,255,393
3,801,718
3,974,257
4,255,167
5,483,247
4,979,729
5,282,221
6,403,894
7,546,118
11,393,272
13,776,128
15,321,353
18,877,013
24,876,945
26,897,656
26,744,945
21,888,144
21,888,14426,744,94526,897,65624,876,94518,877,01315,321,35313,776,12811,393,2727,546,1186,403,8945,282,2214,979,7295,483,2474,255,1673,974,2573,801,7183,255,393821,2281,772,2351,982,6781,584,1381,429,267
       Cash And Cash Equivalents 
504,537
534,133
492,057
388,451
24,518
987,100
1,270,632
937,282
863,269
1,167,512
928,117
1,174,209
1,925,528
2,896,342
4,376,937
4,327,020
4,815,026
8,650,466
11,356,360
11,561,982
12,015,223
6,777,199
6,777,19912,015,22311,561,98211,356,3608,650,4664,815,0264,327,0204,376,9372,896,3421,925,5281,174,209928,1171,167,512863,269937,2821,270,632987,10024,518388,451492,057534,133504,537
       Short-term Investments 
0
0
0
0
-83,478
0
0
0
0
424
342
562
507
467
1,100,094
2,288,264
2,056,756
1,820,203
1,765,678
4,013,636
1,077,054
1,473,112
1,473,1121,077,0544,013,6361,765,6781,820,2032,056,7562,288,2641,100,0944675075623424240000-83,4780000
       Net Receivables 
545,502
0
666,234
0
1,064,806
1,245,269
1,837,999
0
617,142
759,676
0
2,608,479
3,267,653
2,771,158
2,576
13,139
4,915,342
5,784,728
7,984,844
7,623,543
10,128,537
9,938,393
9,938,39310,128,5377,623,5437,984,8445,784,7284,915,34213,1392,5762,771,1583,267,6532,608,4790759,676617,14201,837,9991,245,2691,064,8060666,2340545,502
       Inventory 
311,182
482,471
787,003
684,779
0
1,166,414
861,542
1,026,815
1,328,156
1,628,428
1,449,657
1,443,950
1,523,385
1,730,946
2,423,913
3,039,282
2,836,470
2,206,555
3,034,150
2,868,444
3,138,664
3,130,014
3,130,0143,138,6642,868,4443,034,1502,206,5552,836,4703,039,2822,423,9131,730,9461,523,3851,443,9501,449,6571,628,4281,328,1561,026,815861,5421,166,4140684,779787,003482,471311,182
       Other Current Assets 
87,375
570,557
68,334
0
1,021,309
5,716
44,689
8,808
522,814
2,686,883
2,601,613
55,021
2,954,474
1,028,705
3,493,970
4,129,748
5,204,283
415,062
7,129,079
7,529,433
142,502
569,426
569,426142,5027,529,4337,129,079415,0625,204,2834,129,7483,493,9701,028,7052,954,47455,0212,601,6132,686,883522,8148,80844,6895,7161,021,309068,334570,55787,375
   > Long-term Assets 
2,155,151
3,430,951
3,617,328
3,515,414
1,237,504
3,703,591
4,084,937
4,308,680
4,614,114
5,546,863
4,553,863
4,714,267
4,934,103
5,670,203
6,607,944
9,394,692
14,118,201
16,775,433
17,621,231
19,998,930
21,510,589
22,500,847
22,500,84721,510,58919,998,93017,621,23116,775,43314,118,2019,394,6926,607,9445,670,2034,934,1034,714,2674,553,8635,546,8634,614,1144,308,6804,084,9373,703,5911,237,5043,515,4143,617,3283,430,9512,155,151
       Property Plant Equipment 
1,854,340
3,209,621
3,307,001
3,241,757
215
3,329,459
3,561,408
3,710,080
3,947,244
5,371,212
4,304,712
4,436,092
4,698,163
5,320,258
6,046,121
7,204,814
10,383,225
10,592,913
11,699,213
12,324,223
13,500,493
13,079,000
13,079,00013,500,49312,324,22311,699,21310,592,91310,383,2257,204,8146,046,1215,320,2584,698,1634,436,0924,304,7125,371,2123,947,2443,710,0803,561,4083,329,4592153,241,7573,307,0013,209,6211,854,340
       Goodwill 
62,851
59,411
58,047
55,915
0
93,996
132,810
133,089
132,631
82,706
100,362
100,003
99,973
100,093
101,723
140,474
211,374
177,826
183,469
263,736
234,904
234,904
234,904234,904263,736183,469177,826211,374140,474101,723100,09399,973100,003100,36282,706132,631133,089132,81093,996055,91558,04759,41162,851
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
19,743
76,604
27,586
171,821
426,720
907,435
0
0
0
0
0
0
000000907,435426,720171,82127,58676,60419,7430000000000
       Intangible Assets 
64,433
74,525
63,740
48,405
0
78,658
136,054
176,924
211,816
18,637
99,705
88,991
80,455
70,945
86,215
805,387
1,481,721
781,011
755,779
2,406,049
2,198,549
2,609,506
2,609,5062,198,5492,406,049755,779781,0111,481,721805,38786,21570,94580,45588,99199,70518,637211,816176,924136,05478,658048,40563,74074,52564,433
       Long-term Assets Other 
173,527
87,395
188,541
169,337
-83,478
201,477
254,666
288,587
322,423
424
342
562
507
467
1,100,094
2,616,611
172,729
421,345
513,635
630,605
264,657
1,529,239
1,529,239264,657630,605513,635421,345172,7292,616,6111,100,094467507562342424322,423288,587254,666201,477-83,478169,337188,54187,395173,527
> Total Liabilities 
1,313,392
2,597,598
3,002,321
2,629,656
626,751
2,923,461
3,194,333
3,274,888
3,978,397
5,583,988
3,597,400
3,478,197
3,958,498
4,090,977
5,126,687
7,672,001
7,433,541
7,961,770
9,374,064
11,066,826
11,264,158
10,522,701
10,522,70111,264,15811,066,8269,374,0647,961,7707,433,5417,672,0015,126,6874,090,9773,958,4983,478,1973,597,4005,583,9883,978,3973,274,8883,194,3332,923,461626,7512,629,6563,002,3212,597,5981,313,392
   > Total Current Liabilities 
1,050,418
1,668,330
1,809,165
1,770,850
289,505
2,100,966
2,533,327
2,209,110
3,010,939
5,024,442
2,999,392
2,880,701
2,917,650
3,657,414
4,813,011
7,232,653
6,976,427
7,471,717
8,839,370
10,057,503
10,182,573
9,634,027
9,634,02710,182,57310,057,5038,839,3707,471,7176,976,4277,232,6534,813,0113,657,4142,917,6502,880,7012,999,3925,024,4423,010,9392,209,1102,533,3272,100,966289,5051,770,8501,809,1651,668,3301,050,418
       Short-term Debt 
171,981
266,150
0
0
516
508,067
775,484
275,509
712,921
1,462,942
515,686
499,032
378,467
897,777
927,282
70,589
97,235
390,223
38,424
473,902
599,843
451,195
451,195599,843473,90238,424390,22397,23570,589927,282897,777378,467499,032515,6861,462,942712,921275,509775,484508,06751600266,150171,981
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
1,340,066
624,070
451,966
897,777
774,843
70,449
23,000
99,000
0
153,484
450,216
392,204
392,204450,216153,484099,00023,00070,449774,843897,777451,966624,0701,340,0660000000000
       Accounts payable 
860,131
1,398,033
1,435,068
979,904
0
1,487,049
1,639,873
1,882,219
1,541,503
1,536,277
983,436
967,426
961,130
1,087,438
1,298,945
3,267,336
1,427,020
1,241,566
1,622,617
2,010,065
2,841,739
2,613,000
2,613,0002,841,7392,010,0651,622,6171,241,5661,427,0203,267,3361,298,9451,087,438961,130967,426983,4361,536,2771,541,5031,882,2191,639,8731,487,0490979,9041,435,0681,398,033860,131
       Other Current Liabilities 
0
0
366,469
775,904
288,988
0
32,972
383,057
743,197
1,935,889
2,249,913
1,999,635
1,928,493
1,889,659
2,283,034
3,668,105
5,162,654
5,390,762
5,246,058
7,279,818
6,323,215
6,235,601
6,235,6016,323,2157,279,8185,246,0585,390,7625,162,6543,668,1052,283,0341,889,6591,928,4931,999,6352,249,9131,935,889743,197383,05732,9720288,988775,904366,46900
   > Long-term Liabilities 
262,974
929,269
1,193,156
858,806
337,247
822,494
661,005
1,065,778
967,458
559,546
598,008
597,496
1,040,849
433,562
313,676
439,347
457,114
490,052
534,694
1,009,323
1,081,585
888,674
888,6741,081,5851,009,323534,694490,052457,114439,347313,676433,5621,040,849597,496598,008559,546967,4581,065,778661,005822,494337,247858,8061,193,156929,269262,974
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
85,176
145,406
232,039
243,829
315,578
440,220
473,083
574,412
631,682
0
0
0
000631,682574,412473,083440,220315,578243,829232,039145,40685,1760000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
31,341
27,167
26,200
18,783
14,222
7,022
8,082
14,146
41,983
35,814
0
0
0035,81441,98314,1468,0827,02214,22218,78326,20027,16731,3410000000000
> Total Stockholder Equity
2,262,206
2,406,775
2,586,551
2,648,775
1,431,981
3,959,961
4,543,368
4,892,205
4,775,230
5,303,615
5,823,528
6,460,417
7,317,070
9,050,403
12,803,483
15,022,426
20,651,198
26,478,059
31,788,603
33,903,972
33,203,208
32,264,695
32,264,69533,203,20833,903,97231,788,60326,478,05920,651,19815,022,42612,803,4839,050,4037,317,0706,460,4175,823,5285,303,6154,775,2304,892,2054,543,3683,959,9611,431,9812,648,7752,586,5512,406,7752,262,206
   Common Stock
163,998
163,871
0
0
153,812
135,154
135,145
130,813
123,809
219,449
436,522
7,852,253
8,235,880
9,464,074
10,797,881
11,348,996
12,192,032
12,922,781
13,332,876
12,237,203
12,000,311
11,032,752
11,032,75212,000,31112,237,20313,332,87612,922,78112,192,03211,348,99610,797,8819,464,0748,235,8807,852,253436,522219,449123,809130,813135,145135,154153,81200163,871163,998
   Retained Earnings 
0
0
0
0
0
0
0
0
2,384,629
0
2,474,177
-1,740,577
3,891,517
5,273,885
7,041,693
9,372,919
10,855,814
15,794,323
21,125,822
23,730,112
28,872,724
23,344,080
23,344,08028,872,72423,730,11221,125,82215,794,32310,855,8149,372,9197,041,6935,273,8853,891,517-1,740,5772,474,17702,384,62900000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
2,262,206
2,406,775
2,586,551
2,648,775
1,278,169
3,959,961
4,543,368
4,892,205
-1,769,247
5,303,615
2,790,715
9,278,613
-6,409,746
-3,805,761
10,268,438
1,573,203
-112,649
-119,401
-104,712
-93,985
-9,227,584
-2,112,137
-2,112,137-9,227,584-93,985-104,712-119,401-112,6491,573,20310,268,438-3,805,761-6,409,7469,278,6132,790,7155,303,615-1,769,2474,892,2054,543,3683,959,9611,278,1692,648,7752,586,5512,406,7752,262,206



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue29,009,254
Cost of Revenue-8,710,543
Gross Profit20,298,71120,298,711
 
Operating Income (+$)
Gross Profit20,298,711
Operating Expense-14,932,565
Operating Income5,366,1465,366,146
 
Operating Expense (+$)
Research Development5,190,656
Selling General Administrative1,079,603
Selling And Marketing Expenses8,662,306
Operating Expense14,932,56514,932,565
 
Net Interest Income (+$)
Interest Income-
Interest Expense-43,673
Other Finance Cost-0
Net Interest Income-43,673
 
Pretax Income (+$)
Operating Income5,366,146
Net Interest Income-43,673
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,578,7265,153,566
EBIT - interestExpense = 5,578,726
5,567,936
4,371,708
Interest Expense43,673
Earnings Before Interest and Taxes (EBIT)5,622,3995,622,399
Earnings Before Interest and Taxes (EBITDA)6,961,849
 
After tax Income (+$)
Income Before Tax5,578,726
Tax Provision-1,239,901
Net Income From Continuing Ops4,338,8254,338,825
Net Income4,328,035
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses23,643,108
Total Other Income/Expenses Net212,58043,673
 

Technical Analysis of Cspc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cspc. The general trend of Cspc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cspc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cspc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CSPC Pharmaceutical Group Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.05 < 1.05 < 1.05.

The bearish price targets are: 1.05 > 1.05 > 1.05.

Know someone who trades $CHJTF? Share this with them.👇

CSPC Pharmaceutical Group Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CSPC Pharmaceutical Group Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CSPC Pharmaceutical Group Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CSPC Pharmaceutical Group Ltd. The current macd is 0.05331323.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cspc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cspc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cspc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CSPC Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) ChartCSPC Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CSPC Pharmaceutical Group Ltd. The current adx is 83.57.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cspc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
CSPC Pharmaceutical Group Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CSPC Pharmaceutical Group Ltd. The current sar is 1.13007314.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CSPC Pharmaceutical Group Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CSPC Pharmaceutical Group Ltd. The current rsi is 74.96. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
CSPC Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) ChartCSPC Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CSPC Pharmaceutical Group Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cspc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
CSPC Pharmaceutical Group Ltd Daily Stochastic Oscillator ChartCSPC Pharmaceutical Group Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CSPC Pharmaceutical Group Ltd. The current cci is 18.52.

CSPC Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) ChartCSPC Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CSPC Pharmaceutical Group Ltd. The current cmo is 41.11.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
CSPC Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) ChartCSPC Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CSPC Pharmaceutical Group Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
CSPC Pharmaceutical Group Ltd Daily Williams %R ChartCSPC Pharmaceutical Group Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CSPC Pharmaceutical Group Ltd.

CSPC Pharmaceutical Group Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CSPC Pharmaceutical Group Ltd. The current atr is 0.01011382.

CSPC Pharmaceutical Group Ltd Daily Average True Range (ATR) ChartCSPC Pharmaceutical Group Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CSPC Pharmaceutical Group Ltd. The current obv is -501,010.

CSPC Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) ChartCSPC Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CSPC Pharmaceutical Group Ltd. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
CSPC Pharmaceutical Group Ltd Daily Money Flow Index (MFI) ChartCSPC Pharmaceutical Group Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CSPC Pharmaceutical Group Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

CSPC Pharmaceutical Group Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CSPC Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.962
Ma 20Greater thanMa 501.047
Ma 50Greater thanMa 1000.858
Ma 100Greater thanMa 2000.714
OpenGreater thanClose1.050
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cspc with someone you think should read this too:
  • Are you bullish or bearish on Cspc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cspc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CSPC Pharmaceutical Group Ltd

I send you an email if I find something interesting about CSPC Pharmaceutical Group Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about CSPC Pharmaceutical Group Ltd.

Receive notifications about CSPC Pharmaceutical Group Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.